Colombo, Dec 17 (Daily Mirror) - The National Medicines Regulatory Authority (NMRA) has directed local hospitals to temporarily stop using ten medicinal products until their manufacturing processes are verified to meet required standards, NMRA Chairman Dr. Ananda Wijewickrama said.
Dr. Wijewickrama told the Daily Mirror that an urgent circular has been issued to PTC Medical Pvt. Ltd., instructing the company to withhold all parenteral products manufactured by Maan Pharmaceuticals Ltd., India, until further notice, following safety concerns and reports of adverse drug reactions.
The decision, based on the Safety and Risk Evaluation Subcommittee’s recommendation on 16 December 2025, follows continuous reports of adverse reactions, including fatal cases. Preliminary investigations by a consultant microbiologist at National Hospital, Kandy, also highlighted potential safety risks.
According to the circular, PTC Medical, the market authorization holder, confirmed that the affected products are being withheld across the entire private sector. Further testing is underway at the National Medicines Quality Assurance Laboratory (NMQAL) to ensure their quality, safety, and efficacy.
PTC Medical said that the withdrawal is a precautionary measure and urged all private sector distributors and healthcare providers to comply immediately.
Doctors' Trade Union Alliance for Medical Civil Rights Chairman Dr. Chamal Sanjeewa said the drugs include antibiotics, Ondansetron for vomiting, Haloperidol for mental illnesses and febrile seizures, and Iron Sucrose for deficiency. Most were imported between 2024 and 2025.
Dr. Sanjeewa noted that over 100 batches of medicines from India have been temporarily or permanently withdrawn in the past two years due to quality concerns. He criticized the Health Ministry, Drug Regulatory Authority, and State Pharmaceutical Corporation (SPC) for “collapsed” drug regulation, citing unsafe storage of imported medicines and ongoing regulatory failures.
He called for responsible health administrators to resign and urged the public to obtain medicines only under professional supervision.
This historic withdrawal highlights the urgent need for stricter oversight and reform in the country’s drug regulation and procurement system.
Dr. Dee esquire Wednesday, 17 December 2025 06:31 PM
Have these been imported during the ‘past 75 years government’ ?
Sri Lanka Dengue Cases 2026: Live Tracker and Latest Updates
Rs. 2,500 monthly allowance for pensioners retiring between 2020 and 2024
Wife of former Speaker Chamal Rajapaksa passes away
Did Bing Chun really fail safety tests? The company finally responds
’’Only an inhuman person could dismiss his mother’s condition as non-exceptional’’ - Defence Counsel
Supreme Court upholds Shashi Weerawansa’s two-year prison sentence
Pat Cummins reveals reason behind ’spat’ with wife Becky. It’s Usman Khawaja
SriLankan Airlines increases Melbourne flights to 10 per week
Cyclonic storm threat looms over Sri Lanka as heavy rains forecast
Loading comments…